Empagliflozin Improves Insulin Sensitivity of the Hypothalamus in Humans With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial

DSpace Repository

Empagliflozin Improves Insulin Sensitivity of the Hypothalamus in Humans With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial

Author: Kullmann, Stephanie; Hummel, Julia; Wagner, Robert; Dannecker, Corinna; Vosseler, Andreas; Fritsche, Louise; Veit, Ralf; Kantartzis, Konstantinos; Machann, Juergen; Birkenfeld, Andreas L.; Stefan, Norbert; Haering, Hans-Ulrich; Peter, Andreas; Preissl, Hubert; Fritsche, Andreas; Heni, Martin
Tübinger Autor(en):
Kullmann, Stephanie
Hummel, Julia
Dannecker, Corinna
Vosseler, Andreas
Fritsche, Louise
Veit, Ralf
Kantartzis, Konstantinos
Birkenfeld, Andreas L.
Stefan, Norbert
Peter, Andreas
Heni, Martin
Wagner, Róbert
Machann, Jürgen
Häring, Hans-Ulrich
Preißl, Hubert
Fritsche, Andreas Erwin
Published in: Diabetes Care (2022), Bd. 45, H. 2, S. 398-406
Verlagsangabe: Amer Diabetes Assoc
Language: English
Full text: http://dx.doi.org/10.2337/dc21-1136
ISSN: 0149-5992
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)